These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3926276)

  • 1. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ; Hott M; Garba MT
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
    Marie PJ; Hott M; Garba MT
    Bone; 1985; 6(3):193-200. PubMed ID: 4027097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase inhibition by levamisole prevents 1,25-dihydroxyvitamin D3-stimulated bone mineralization in the mouse.
    Garba MT; Marie PJ
    Calcif Tissue Int; 1986 May; 38(5):296-302. PubMed ID: 3087604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
    Lerner UH; Larsson A
    Bone; 1987; 8(3):179-89. PubMed ID: 2955802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ; Travers R
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting effects of 1,25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse.
    Marie PJ; Hott M; Garba MT
    Metabolism; 1985 Aug; 34(8):777-83. PubMed ID: 3839559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM; Chambers TJ
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.
    Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L
    J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anabolic action of 17 beta-estradiol (E2) on rat trabecular bone is suppressed by (3-amino-1-hydroxypropylidene)-1-bisphosphonate (AHPrBP).
    Abe T; Chow JW; Lean JM; Chambers TJ
    Bone Miner; 1992 Oct; 19(1):21-9. PubMed ID: 1422303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG; Baylink DJ; Sherrard DJ
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of magnesium supplementation on bone turnover in the normal young mouse.
    Marie PJ; Travers R; Delvin EE
    Calcif Tissue Int; 1983 Sep; 35(6):755-61. PubMed ID: 6652550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice.
    Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y
    Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of bone formation by dynamic mechanical loading of rat caudal vertebrae is not suppressed by 3-amino-1-hydroxypropylidene-1-bisphosphonate (AHPrBP).
    Jagger CJ; Chambers TJ; Chow JW
    Bone; 1995 Mar; 16(3):309-13. PubMed ID: 7786634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of rachitic rat bones to 1,25-dihydroxyvitamin D3: biphasic effects on mineralization and lack of effect on bone resorption.
    Gallagher JA; Beneton M; Harvey L; Lawson DE
    Endocrinology; 1986 Oct; 119(4):1603-9. PubMed ID: 3757903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of calcium absorption by 1,25,dihydroxy-vitamin D--studies of the effects of a bisphosphonate treatment.
    Adami S; Frijlink WB; Bijvoet OL; O'Riordan JL; Clemens TL; Papapoulos SE
    Calcif Tissue Int; 1982 Jul; 34(4):317-20. PubMed ID: 6814718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.
    Netelenbos JC; van Ginkel FC; Lips P; Leeuwenkamp OR; Barto R; van der Vijgh WJ; van der Wiel H; Hackeng WH
    J Clin Endocrinol Metab; 1991 Jan; 72(1):223-8. PubMed ID: 1986022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of various bisphosphonates.
    Shinoda H; Adamek G; Felix R; Fleisch H; Schenk R; Hagan P
    Calcif Tissue Int; 1983; 35(1):87-99. PubMed ID: 6839194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.